










 





Insider Trading - Versant Affiliates Fund V L.P. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Versant Affiliates Fund V L.P.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-10-24Purchase(A)
2016-12-236:03 pm
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
161,000
$14
$2,254,000
4,104,045(Indirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 23:27:08 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  











Insider Trading - Versant Venture Capital Iv L.P. - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Versant Venture Capital Iv L.P.





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-10-24Purchase(A)
2016-12-236:03 pm
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
161,000
$14
$2,254,000
4,104,045(Indirect)
View




 (A) Indicate amendment filing.
 Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
437,247
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,754
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
3,100,477
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
19,524
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
2,210,417
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
66,490
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
168,224
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
73,704
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
231,077
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
1,454
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
173,167
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,210
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
13,180
$0
4,104,045(Indirect)
View


2016-10-24Conversion
2016-12-236:03 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Affiliates Fund V L.P.Versant Ophthalmic Affiliates I L.P.Versant Venture Capital V (canada) Lp10% Owner
5,774
$0
4,104,045(Indirect)
View


2016-10-24Option Award
2016-10-266:28 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Venture Capital V (canada) Lp10% Owner
95,596
$14
4,104,045(Indirect)
View


2016-10-24Option Award
2016-10-266:28 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Venture Capital V (canada) Lp10% Owner
602
$14
4,104,045(Indirect)
View


2016-10-24Option Award
2016-10-266:28 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Venture Capital V (canada) Lp10% Owner
60,219
$14
4,104,045(Indirect)
View


2016-10-24Option Award
2016-10-266:28 pm
N/AN/A
Crispr Therapeutics Ag
CRSP
Versant Venture Capital Iv L.P.Versant Side Fund Iv L.P.Versant Venture Capital V L.P.Versant Venture Capital V (canada) Lp10% Owner
4,583
$14
4,104,045(Indirect)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 23:27:08 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Versant Venture Capital IV, L.P. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Versant Venture Capital IV, L.P.
Check out list of companies and businesses related to Versant Venture Capital IV, L.P.. Find out Versant Venture Capital IV, L.P. address and contact details. View other people related to Versant Venture Capital IV, L.P. - coworkers, colleagues, companions, etc.
Address:   

3000 SAND HILL ROAD, BLDG 4, SUITE 210  MENLO PARK 94025 CA




Companies related to Versant Venture Capital IV, L.P.
CIKCompany NamePositionCompany Address0001466301Clovis Oncology, Inc.10% Owner 5500 FLATIRON PARKWAY SUITE 100 BOULDER 80301




Versant Venture Capital IV, L.P. on the Web
Persons related to Versant Venture Capital IV, L.P. - Clovis Oncology, Inc.NamePositionCityAndrew R  AllenSee Remarks BOULDERAndrew R  AllenSee Remarks BOULDERAllen  AndrewBoulderAllen  AndrewBoulderAllen  AndrewBoulderBRIAN G  ATWOODDirector MENLO PARKBRIAN G  ATWOODMENLO PARKBRIAN G  ATWOODDirector MENLO PARKM JAMES  BARRETTDirector BALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner TIMONIUMJAMES C  BLAIRDirector PRINCETONAtwood  BrianBoulderASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VII ASSOCIATES LP10% Owner PRINCETONRYAN D  DRANT10% Owner TIMONIUMMcKinley  EdwardBoulderMast  ErleBoulderMast  ErleBoulderKeith T.  FlahertyDirector BOULDERIvers-Read  GillianBoulderIvers-Read  GillianBoulderGraham  GingerBoulderGINGER L  GRAHAMDirector GINGER L  GRAHAMDirector BOULDERBrian K  Halak10% Owner PRINCETONSteven L.  HoerterSee Remarks BOULDERCorwin Dale  HooksSee Remarks BOULDERGILLIAN C  IVERS-READSee Remarks BOULDERGILLIAN C  IVERS-READSee Remarks BOULDERBlair  JamesBoulderKim P.  KamdarPRINCETONFlaherty  KeithBoulderPATRICK J  KERINS10% Owner TIMONIUMPAUL H  KLINGENSTEINDirector PALO ALTOPAUL H  KLINGENSTEINDirector SAN FRANCISCOKRISHNA KITTU  KOLLURI10% Owner TIMONIUMC RICHARD  KRAMLICH10% Owner TIMONIUMBarret  M.BoulderPATRICK J  MAHAFFYSee Remarks BOULDERPATRICK J  MAHAFFYSee Remarks BOULDERERLE T  MASTExecutive VP and CFO BOULDERERLE T  MASTExecutive VP and CFO BOULDER,ERLE T  MASTExecutive VP and CFO BOULDEREdward J  McKinleyDirector LONDON SW10 9NF UNITED KINGDOMEdward J  McKinleyDirector BOULDERDAVID M  MOTT10% Owner TIMONIUMDANIEL W  MUEHLSee Remarks NORTH BILLERCANEA 13 GP, LtdTIMONIUMPartners 13, Limited Partnership  NEA10% Owner TIMONIUMNEW ENTERPRISE ASSOCIATES 13 LP10% Owner TIMONIUMMahaffy  PatrickBoulderMahaffy  PatrickBoulderMahaffy  PatrickBoulderKlingenstein  PaulBoulderJOHN C  REEDDirector BOULDERLindsey  RolfeSee Remarks BOULDERSCOTT D  SANDELL10% Owner TIMONIUMKATHLEEN K  SCHOEMAKER10% Owner PRINCETONTHORLEF  SPICKSCHENDirector GERMANYTHORLEF  SPICKSCHENDirector BOULDERHoerter  StevenBoulderSpickschen  ThorlefBoulderJESSE I  TREU10% Owner PRINCETONVersant Side Fund IV, L.P.MENLO PARKVersant Side Fund IV, L.P.MENLO PARKVersant Side Fund IV, L.P.MENLO PARKVersant Ventures IV, LLCMENLO PARKVersant Ventures IV, LLCMENLO PARKVersant Ventures IV, LLCMENLO PARKRavi  Viswanathan10% Owner TIMONIUMNICOLE  VITULLO10% Owner PRINCETONHarry R  Weller10% Owner TIMONIUM
Potentially same personNameCityCountryVersant Venture Capital IV, L.P.MENLO PARKCAVersant Venture Capital IV, L.P.MENLO PARKCA












 








Versant Side Fund IV, L.P. - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Versant Side Fund IV, L.P.
Check out list of companies and businesses related to Versant Side Fund IV, L.P.. Find out Versant Side Fund IV, L.P. address and contact details. View other people related to Versant Side Fund IV, L.P. - coworkers, colleagues, companions, etc.
Address:   

3000 SAND HILL ROAD BLDG 4, SUITE 210 MENLO PARK 94025 CA




Companies related to Versant Side Fund IV, L.P.
CIKCompany NamePositionCompany Address0001466301Clovis Oncology, Inc.5500 FLATIRON PARKWAY SUITE 100 BOULDER 80301




Versant Side Fund IV, L.P. on the Web
Persons related to Versant Side Fund IV, L.P. - Clovis Oncology, Inc.NamePositionCityAndrew R  AllenSee Remarks BOULDERAndrew R  AllenSee Remarks BOULDERAllen  AndrewBoulderAllen  AndrewBoulderAllen  AndrewBoulderBRIAN G  ATWOODDirector MENLO PARKBRIAN G  ATWOODMENLO PARKBRIAN G  ATWOODDirector MENLO PARKM JAMES  BARRETTDirector BALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner TIMONIUMFOREST  BASKETT10% Owner TIMONIUMJAMES C  BLAIRDirector PRINCETONAtwood  BrianBoulderASSOCIATES  DOMAINPRINCETONDOMAIN PARTERS VII L P10% Owner PRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP VII ASSOCIATES LP10% Owner PRINCETONRYAN D  DRANT10% Owner TIMONIUMMcKinley  EdwardBoulderMast  ErleBoulderMast  ErleBoulderKeith T.  FlahertyDirector BOULDERIvers-Read  GillianBoulderIvers-Read  GillianBoulderGraham  GingerBoulderGINGER L  GRAHAMDirector GINGER L  GRAHAMDirector BOULDERBrian K  Halak10% Owner PRINCETONSteven L.  HoerterSee Remarks BOULDERCorwin Dale  HooksSee Remarks BOULDERGILLIAN C  IVERS-READSee Remarks BOULDERGILLIAN C  IVERS-READSee Remarks BOULDERBlair  JamesBoulderKim P.  KamdarPRINCETONFlaherty  KeithBoulderPATRICK J  KERINS10% Owner TIMONIUMPAUL H  KLINGENSTEINDirector PALO ALTOPAUL H  KLINGENSTEINDirector SAN FRANCISCOKRISHNA KITTU  KOLLURI10% Owner TIMONIUMC RICHARD  KRAMLICH10% Owner TIMONIUMBarret  M.BoulderPATRICK J  MAHAFFYSee Remarks BOULDERPATRICK J  MAHAFFYSee Remarks BOULDERERLE T  MASTExecutive VP and CFO BOULDERERLE T  MASTExecutive VP and CFO BOULDER,ERLE T  MASTExecutive VP and CFO BOULDEREdward J  McKinleyDirector LONDON SW10 9NF UNITED KINGDOMEdward J  McKinleyDirector BOULDERDAVID M  MOTT10% Owner TIMONIUMDANIEL W  MUEHLSee Remarks NORTH BILLERCANEA 13 GP, LtdTIMONIUMPartners 13, Limited Partnership  NEA10% Owner TIMONIUMNEW ENTERPRISE ASSOCIATES 13 LP10% Owner TIMONIUMMahaffy  PatrickBoulderMahaffy  PatrickBoulderMahaffy  PatrickBoulderKlingenstein  PaulBoulderJOHN C  REEDDirector BOULDERLindsey  RolfeSee Remarks BOULDERSCOTT D  SANDELL10% Owner TIMONIUMKATHLEEN K  SCHOEMAKER10% Owner PRINCETONTHORLEF  SPICKSCHENDirector GERMANYTHORLEF  SPICKSCHENDirector BOULDERHoerter  StevenBoulderSpickschen  ThorlefBoulderJESSE I  TREU10% Owner PRINCETONVersant Venture Capital IV, L.P.MENLO PARKVersant Venture Capital IV, L.P.10% Owner MENLO PARKVersant Venture Capital IV, L.P.10% Owner MENLO PARKVersant Ventures IV, LLCMENLO PARKVersant Ventures IV, LLCMENLO PARKVersant Ventures IV, LLCMENLO PARKRavi  Viswanathan10% Owner TIMONIUMNICOLE  VITULLO10% Owner PRINCETONHarry R  Weller10% Owner TIMONIUM
Potentially same personNameCityCountryVersant Side Fund IV, L.P.MENLO PARKCAVersant Side Fund IV, L.P.MENLO PARKCA












 








Versant Venture Capital III, L.P.: Private Company Information - Bloomberg









































  





















































































July 29, 2017 12:27 AM ET
Capital Markets

Company Overview of Versant Venture Capital III, L.P.



Snapshot People




Company Overview
Versant Venture Capital III, L.P. specializes in incubation, seed, start-ups, and early venture. It seeks to invest in healthcare and life sciences companies. The fund makes investments across the entire spectrum of the life sciences venture space, investing roughly similar amounts in drug development opportunities and medical device companies, with less attention paid to health care service. It also seeks to make investment in healthcare industry software sector. It prefers to invest around $10 million over the life of an investment. Versant Venture Capital III, L.P. is comprised of parallel fund Versant Side Fund III, L.P.


One Sansome StreetSuite 3630San Francisco, CA 94104United StatesFounded in 2005



Phone: 415-801-8100

Fax: 415-801-8101








Key Executives for Versant Venture Capital III, L.P.




Ms. Barbara N. Lubash MS


      	Managing Director
      








Mr. Donald B. Milder


      	Managing Director
      


Age: 62
        







Ms. Rebecca B. Robertson


      	Managing Director
      








Mr. Brian G. Atwood Veracyte


      	Co-founder & MD
      


Age: 64
        







Mr. William J. Link Ph.D.


      	Co-Founder & MD
      


Age: 71
        




Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Versant Venture Capital III, L.P., please visit --.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Versant Venture Capital IV, L.P.: Private Company Information - Bloomberg










































  





















































































July 29, 2017 12:27 AM ET
Capital Markets

Company Overview of Versant Venture Capital IV, L.P.



Snapshot People




Company Overview
Versant Venture Capital IV, L.P. specializes in early stage, seed, and later stage investments. The fund seeks to invest in the healthcare sector with a focus on early stage medical device, biotech, and pharmaceutical companies. Versant Venture Capital IV, L.P. is comprised of Versant Side Fund IV, L.P.


One Sansome StreetSuite 3630San Francisco, CA 94104United StatesFounded in 2008



Phone: 415-801-8100

Fax: 415-801-8101








Key Executives for Versant Venture Capital IV, L.P.




Mr. Ross A. Jaffe M.D.


      	MD and Partner
      


Age: 57
        







Mr. Brian G. Atwood Veracyte


      	Co-founder & MD
      


Age: 64
        







Mr. Samuel D. Colella MBA


      	Managing Director
      


Age: 77
        







Mr. William J. Link Ph.D.


      	Co-Founder & MD
      


Age: 71
        







Ms. Rebecca B. Robertson


      	Managing Director
      





Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Versant Venture Capital IV, L.P., please visit --.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close































SEC Info - "Samuel D. Colella"










SEC Info uses JavaScript!  To view pages properly, enable JavaScript in your browser.


    SEC Info      Home      Search      My Interests      Help      Sign In      Please Sign In



“Samuel D. Colella”a.k.a. “Samuel D Colella”Latest Filing:  7/27/17 as RegistrantAs:  RegistrantColella Samuel DAs:  Group Member  (Non-Registrant Filer:  Partner, Affiliate, etc.)List all Filings as Group MemberSearch Recent Filings (as Group Member) for “Samuel D. Colella”“Samuel D. Colella” has been a Group Member with the following 11 Registrants:Institutional Venture Partners VIInstitutional Venture Partners VIIInstitutional Venture Partners VIIIVersant Affiliates Fund II-A, LPVersant Side Fund III, L.P.Versant Side Fund IV, L.P.Versant Venture Capital I LPVersant Venture Capital III, L.P.Versant Ventures I LLCVersant Ventures II LLCVersant Ventures III, LLC“Samuel D. Colella” has/had a Group Member interest in the following 34 Registrants:@Road, Inc [ formerly At Road Inc ]Achaogen IncAlexza Pharmaceuticals Inc.Argonaut Technologies IncCadence Pharmaceuticals IncClovis Oncology, Inc.CymaBay Therapeutics, Inc. [ formerly Metabolex, Inc. ]Digital Impact Inc/DEFive Prime Therapeutics IncFlexion Therapeutics IncFluidigm CorpFormfactor IncGenomic Health IncGlaukos CorpHelicos Biosciences CorpImmune Design Corp. [ formerly Vaccsys Inc ]Inogen IncInsulet CorpIntralase CorpJazz Pharmaceuticals plc [ formerly Jazz Pharmaceuticals Inc ]Kythera Biopharmaceuticals IncNetflix Inc [ formerly Netflix Com Inc ]Ocular Therapeutix, Inc [ formerly I-Therapeutix Inc ]Opgen IncParatek Pharmaceuticals, Inc. [ formerly Transcept Pharmaceuticals Inc ]Pharmion CorpPhaserx, Inc.Second Sight Medical Products IncSolta Medical Inc [ formerly Thermage Inc ]Tivo Solutions Inc. [ formerly Tivo Inc ]Transmeta CorpTrius Therapeutics IncTurnstone Systems IncVeracyte, Inc. [ formerly Calderome Inc ]“Samuel D. Colella” has been a Group Member with the following 56 Group Members:Barbara N LubashBradley J BolzonBrain G. AtwoodBrian G AtwoodBroadband Fund LPCamille D SamuelsCharles M WardenDonald B MidlerDonald B MilderGeoffrey Y YangInstitutional Venture Management VI, L.PInstitutional Venture Management VII LPInstitutional Venture Management VIII, LLCInstitutional Venture Partners VI, L.PInstitutional Venture Partners VII, L.P.Institutional Venture Partners VIII, L.P.Ivm Investment Fund VII-A, LLCIvm Investment Fund VIII, LLCIvm Investment Fund VIII-A, LLCIvp Founders Fund I LPIvp Founders Fund I, L.PKevin J. WassersteinKirk G. NielsenL James StrandMary Jane ElmoreNorman A FogelsongPeter T. ThomasR. Thomas DyalRebecca B RobertsonRebecca B. RoberstonReid W DennisRobin L PraegerRoss A JaffeRoss A. Jaffe, M.D.Ruthann QuindlenThomas F. WoiwodeTimothy M. HaleyVersant Affiliates Fund I-A LPVersant Affiliates Fund I-B LPVersant Affiliates Fund II-A LPVersant Development Fund III, LLCVersant Side Fund I LPVersant Side Fund II LPVersant Side Fund III, L.P.Versant Side Fund IV, L.P.Versant Venture Capital I LPVersant Venture Capital II LPVersant Venture Capital III, L.P.Versant Venture Capital IV, L.P.Versant Ventures I, L.L.C.Versant Ventures II, L.L.C.Versant Ventures III, L.L.C.Versant Ventures IV, LLCWilliam J LinkWilliam J. Link, Ph.DWilliam P TaiAs:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)List all Filings as SignatorySearch Recent Filings (as Signatory) for “Samuel D. Colella”“Samuel D. Colella” has been a Signatory for/with the following First 20 of 44 Registrants:Accelrys, Inc. [ formerly Pharmacopeia Inc ]Alaris Medical Systems Inc [ formerly Alaris Medical Inc ]Alexza Pharmaceuticals Inc.Argonaut Technologies IncAtwood Brian GAzur Pharma Public Ltd Co [ formerly Azur Pharma Ltd ]Bolzon Bradley J PhDColella Samuel DCV Therapeutics IncDoubletwist IncFlexion Therapeutics IncFluidigm CorpGenomic Health IncImagyn Medical IncInstitutional Venture Management VII LPInstitutional Venture Partners VIIIntegrated Medical Resources IncIvac Medical Systems Inc [ formerly Ivac Corp ]Jaffe Ross A MDJazz Pharmaceuticals plc [ formerly Jazz Pharmaceuticals Inc ]List all Registrants“Samuel D. Colella” has/had a Signatory interest in the following 17 Registrants:Alexza Pharmaceuticals Inc.Flexion Therapeutics IncFluidigm CorpGenomic Health IncGlaukos CorpHelicos Biosciences CorpImmune Design Corp. [ formerly Vaccsys Inc ]Insulet CorpIntralase CorpJazz Pharmaceuticals plc [ formerly Jazz Pharmaceuticals Inc ]Kythera Biopharmaceuticals IncParatek Pharmaceuticals, Inc. [ formerly Transcept Pharmaceuticals Inc ]Solta Medical Inc [ formerly Thermage Inc ]Symyx Technologies IncTransmeta CorpTrius Therapeutics IncVeracyte, Inc. [ formerly Calderome Inc ]
Copyright © 2017 Fran Finnegan & Company.  All Rights Reserved.About – Privacy – Redactions – Help —
Sat, 29 Jul 04:27:09.1 GMT 
﻿

Company Profile








































 











 Add Company


Sign in with 
Sign in with 




















Add Company


Add Event


Sign in with 


Sign in with 


Android


iPhone









Companies
Events



 Company
 Events






















Message this company



Message the business




































Message this company


Message the business 













 Post your social media updates






































Network























































































Would you like BusinessVibes to send this message to similar companies in this industry?















Profile Visits

Prev. Visits :
Total :
Current :







Share and improve this company’s performance.
Boost this company’s visibility by sharing it with your contacts






About Company
Financial Details













 























































































































X

Receive updates from "Textiles" companies in "India" for free

Receive updates from "Textiles" companies in "India" for free










*



*











Already a BusinessVibes member? Login




What kind of updates will I receive?
 Latest business listings as they become available
 Current trends that are making noise in your industry
 Reports and articles about your market pushed directly to you
 You will also receive early access to the BusinessVibes mobile app


Access to full profiles can help you
 Instantly contact businesses directly
 Pursue and qualify leads for your business
 Research and find business offerings that you seek
 You will also receive early access to the BusinessVibes mobile app








X

We're glad that you're back. Simply Login and unlock full profile



Easy one click Login Don't worry, we never post without your permission.


- - - - - - - - Or - - - - - - - -
Already an active user? Login with your email



*



*
Forgot password?




New to BusinessVibes? Sign up






X


Receive updates from "Textiles" companies in "India" for free




























Already in BusinessVibes? Login




Access to open trade requests can help you
 Find products and services early
 Less Competition for trade requests
 More cost-effective than traditional trade requests







 














 






Versant Side Fund III, L.P. Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Versant Side Fund III, L.P.
                    

•   SAN FRANCISCO, CA
                      
How do I update this listing?




                                             Versant Side Fund Iii is based out of San Francisco.    WhaleWisdom has at least 10 13D/G filings in our database for Versant Side Fund Iii.
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Versant Side Fund III, L.P., enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




versant side fund iii, l.p.


ONE SANSOME STREET

SAN FRANCISCO
CA
                                                        
                                                    94104


              Business Phone:
              650-233-2211
SEC SIC CODE:2834-PHARMACEUTICAL PREPARATIONS







Recent SEC Filings




4 filed on 06/10/2016
4 filed on 05/24/2016
3/A filed on 05/24/2016
3 filed on 05/17/2016
SC 13G/A filed on 02/10/2016
SC 13G/A filed on 02/10/2016
4 filed on 06/15/2015
4 filed on 06/11/2015
4 filed on 05/12/2015
3 filed on 05/06/2015











Current 13D/G Holdings


Stock
Sector
Shares Held
Market Value
Rank
Source
Source Date





VERACYTE INC (VCYT)


      HEALTH CARE
    

      3,626,236
    

      26,108,899.20
    

      1
    

      13G
    

      2015-12-31
    



OCULAR THERAPETX (OCUL)


      HEALTH CARE
    

      2,222,343
    

      20,823,353.91
    

      2
    

      13G
    

      2015-12-31
    



Trius Therapeutics Inc (TSRX)


      HEALTH CARE
    

      3,281,141
    

      15,683,853.98
    

      3
    

      13G
    

      2012-12-31
    



Unknown (unknown)




      2,965,555
    



      4
    

      13G
    

      2014-12-31
    











Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















